Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma [Phase 2]
Phase 2 clinical trial evaluating binimetinib in combination with imatinib for unresectable KIT-mutant melanoma (Stage III-IV) is currently …
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors [Phase 1]
Phase 1 study of MEM-288 oncolytic virus in advanced solid tumors, evaluating MEM-288 alone and in combination with standard-of-care therapy…
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18) [Phase 3]
Phase 3 trial evaluating IO102-IO103 in combination with pembrolizumab versus pembrolizumab alone in advanced/metastatic/unresectable melano…
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy [Phase 1]
A Phase 1 trial update describes a feasibility study using immune recall to boost responses to checkpoint inhibitors in melanoma, currently …
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: Statins and prOgression of Coronary atheRosclerosis in melanomA Patients Treated With chEckpoint inhibitorS
A clinical trial update shows that recruitment is ongoing to study whether statins affect progression of coronary atherosclerosis in melanom…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-24Clinical Trial Update: To Evaluate the Safety and Efficacy of ADP-TILIL7 in Patients With Locally Advanced or Metastatic Melanoma [Phase 1]
A Phase 1 clinical trial evaluating the safety and potential efficacy of ADP-TILIL7 in patients with locally advanced or metastatic melanoma…
-
CLINICAL_TRIALS research · 2025-08-24Clinical Trial Update: A Study of ST-1898 for Unresectable or Metastatic Melanoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating ST-1898 for unresectable or metastatic melanoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: Flu Vaccine Responses in the Setting of Melanoma Treatment [Phase 4]
Phase 4 clinical trial update examining flu vaccine responses in patients undergoing melanoma treatment to understand vaccine effectiveness …
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Pan-tumor MRD Study
Paradigm Health's Pan-tumor MRD study (NCT06605404) is currently recruiting across several solid tumor indications including bladder, esopha…
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Ipilumumab and Nivolumab With or Without Hypofractionated Radiotherapy in Patients With Metastatic Melanoma [Phase 2]
A Phase 2 clinical trial at Penn Medicine evaluating ipilimumab and nivolumab with or without hypofractionated radiotherapy in patients with…
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: Study of Melanoma-Resistant PET Monitoring Based on Key Rate-limiting Enzymes for Fatty Acid Metabolism in Healthy Volunteers [NA]
A clinical trial from Xijing Hospital is evaluating a PET monitoring approach for melanoma based on key rate-limiting enzymes in fatty acid …
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Omitting Therapeutic Lymph Node Dissection in Patients With Melanoma (Stage 3) and Major Pathological Response in the Index Lymph Node [NA]
A clinical trial update about omitting therapeutic lymph node dissection in stage 3 melanoma and observing major pathological response in th…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 study of APG-115 alone or with pembrolizumab in metastatic melanoma and other advanced solid tumors; the trial is currently active…
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 trial update for TRK-950 in combination with anti-cancer regimens in patients with advanced solid tumors; the study is active but no…
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: A Model for Genetic Susceptibility: Melanoma
A clinical trial update from Memorial Sloan Kettering Cancer Center describes a model for genetic susceptibility in melanoma; the study is c…
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: Immunotherapy With Ipilimumab and Nivolumab Preceded or Not by a Targeted Therapy With Encorafenib and Binimetinib [Phase 2]
Phase 2 trial evaluating ipilimumab and nivolumab with or without encorafenib and binimetinib in unresectable stage III or stage IV melanoma…
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: MoleGazer Development Feasibility Study [NA]
A feasibility study named MoleGazer led by Oxford University Hospitals NHS Trust is in development for melanoma and benign moles, with statu…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: eFLASH for Skin Lesions of Malignant Melanomas [NA]
This clinical trial update describes NCT06549439, evaluating eFLASH for skin lesions of metastatic melanoma, sponsored by the University of …
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: OH2 Injection in Solid Tumors [Phase 1, Phase 2]
This update notes a Phase 1/Phase 2 trial of OH2 Injection for solid tumors and melanoma, currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: OH2 Injection in Melanoma [Phase 3]
OH2 Injection is in Phase 3 clinical trials for melanoma. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: Outcomes of Nivolumab in Combination With Relatlimab in Patients With Advanced Melanoma in the Flatiron Database
This clinical trial update reports real-world outcomes for patients with advanced melanoma treated with the nivolumab and relatlimab combina…
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: French Clinical Datbase of Melanoma Patients (RIC-Mel)
A French registry study (RIC-Mel) led by Nantes University Hospital to collect data on melanoma of the skin; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas [Phase 1, Phase 2]
A Phase I/II clinical trial evaluating DYP688 in patients with metastatic uveal melanoma and other GNAQ/11-mutant melanomas; the study is cu…
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: An International Study on Pediatric Patients With Rare Tumors.
An international pediatric clinical trial study focused on rare tumors is currently recruiting, covering multiple tumor types.
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: In Vivo Real-time Detection of Circulating Melanoma Cells
The University of Arkansas is conducting a study to enable in vivo real-time detection of circulating melanoma cells in patients with melano…